<DOC>
	<DOC>NCT00542867</DOC>
	<brief_summary>The survey try to establish the proportion of patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the Third Joint European Task Force guidelines, overall and by country.Â·</brief_summary>
	<brief_title>Pan-European Survey on the Under Treatment of Hypercholesterolemia</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<criteria>Patients had to be on a lipidlowering drug treatment for at least 3 months, with no dose change for a minimum of 6 weeks.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>Hypercholesterolemia</keyword>
	<keyword>Third Joint European Task Force guidelines</keyword>
	<keyword>Survey</keyword>
</DOC>